Thomas Mayr

Bonn, NW 53127, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Neuropilin2 in Mesenchymal Stromal Cells as a Potential Novel Therapeutic Target in Myelofibrosis.

Neuropilin2 in Mesenchymal Stromal Cells as a Potential Novel Therapeutic Target in Myelofibrosis.

Journal: Cancers

Published: April 24, 2024

Clinical implications of AGR2 in primary prostate cancer: Results from a large-scale study.

Clinical implications of AGR2 in primary prostate cancer: Results from a large-scale study.

Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica

Published: November 26, 2023

Androgen Receptor Splice Variants Contribute to the Upregulation of DNA Repair in Prostate Cancer.

Androgen Receptor Splice Variants Contribute to the Upregulation of DNA Repair in Prostate Cancer.

Journal: Cancers

Published: July 18, 2022

RNA Sequencing Reveals Alterations and Similarities in Cell Metabolism, Hypoxia and Immune Evasion in Primary Cell Cultures of Clear Cell Renal Cell Carcinoma.

RNA Sequencing Reveals Alterations and Similarities in Cell Metabolism, Hypoxia and Immune Evasion in Primary Cell Cultures of Clear Cell Renal Cell Carcinoma.

Journal: Frontiers in oncology

Published: February 24, 2022

Neuropilin-2 regulates androgen-receptor transcriptional activity in advanced prostate cancer.

Neuropilin-2 regulates androgen-receptor transcriptional activity in advanced prostate cancer.

Journal: Oncogene

Published: September 23, 2021

Competition for nutrients or cell intrinsic programming? - Metabolic mechanisms behind the tumor promoting immune microenvironment in cancer.

Competition for nutrients or cell intrinsic programming? - Metabolic mechanisms behind the tumor promoting immune microenvironment in cancer.

Journal: Signal transduction and targeted therapy

Published: April 27, 2021

Neuropilin-2 and Its Transcript Variants Correlate with Clinical Outcome in Bladder Cancer.

Neuropilin-2 and Its Transcript Variants Correlate with Clinical Outcome in Bladder Cancer.

Journal: Genes

Published: February 15, 2021

Retraction Notice to: The Cancer-Associated FGFR4-G388R Polymorphism Enhances Pancreatic Insulin Secretion and Modifies the Risk of Diabetes.

Retraction Notice to: The Cancer-Associated FGFR4-G388R Polymorphism Enhances Pancreatic Insulin Secretion and Modifies the Risk of Diabetes.

Journal: Cell metabolism

Published: October 07, 2020

Targeting glycolysis with 2-deoxy-D-glucose sensitizes primary cell cultures of renal cell carcinoma to tyrosine kinase inhibitors.

Targeting glycolysis with 2-deoxy-D-glucose sensitizes primary cell cultures of renal cell carcinoma to tyrosine kinase inhibitors.

Journal: Journal of cancer research and clinical oncology

Published: November 25, 2019

Linking NRP2 With EMT and Chemoradioresistance in Bladder Cancer.

Linking NRP2 With EMT and Chemoradioresistance in Bladder Cancer.

Journal: Frontiers in oncology

Published: August 02, 2019

Neuropilin-2 is an independent prognostic factor for shorter cancer-specific survival in patients with acinar adenocarcinoma of the prostate.

Neuropilin-2 is an independent prognostic factor for shorter cancer-specific survival in patients with acinar adenocarcinoma of the prostate.

Journal: International journal of cancer

Published: April 07, 2019

Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnostics.

Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnostics.

Journal: Virchows Archiv : an international journal of pathology

Published: August 22, 2017

Showing 1-12 of 15

Last Updated: 09/26/2026